Stay updated on Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial
Sign up to get notified when there's something new on the Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial page.

Latest updates to the Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check24 days agoChange DetectedThe page has been updated to include new drug classifications related to diabetes treatment, specifically mentioning meglitinides, SGLT-2 inhibitors, sulphonylureas, and thiazolidinediones. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference6%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check45 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check82 days agoChange DetectedThe web page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check97 days agoChange DetectedThe website has updated to revision v2.14.2, and users may experience performance issues due to heavy traffic on some NLM-NCBI services; assistance is available through their Help Desk.SummaryDifference0.7%
Stay in the know with updates to Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial page.